DelveInsight

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.


Research Reports By DelveInsight

Found 2322 publications
Sipralexoro - API Insights, 2017 US$ 500.00 Nov, 2017 30 pages
Restex- Drug Insights, 2017 US$ 1,000.00 Nov, 2017 35 pages
Pristiq - API Insights, 2017 US$ 500.00 Nov, 2017 30 pages
Norvir SEC- Drug Insights, 2017 US$ 1,000.00 Nov, 2017 35 pages
Mucosta- Drug Insights, 2017 US$ 1,000.00 Nov, 2017 35 pages
Lamictal - API Insights, 2017 US$ 500.00 Nov, 2017 30 pages
Gastric Ulcers - Pipeline Insight, 2017 US$ 1,250.00 Nov, 2017 50 pages
Eylia- Drug Insights, 2017 US$ 1,000.00 Nov, 2017 35 pages
Dyskinesia - Pipeline Insight, 2017 US$ 1,500.00 Nov, 2017 70 pages
Copaxone- Drug Insights, 2017 US$ 1,000.00 Nov, 2017 35 pages
Botulism - Pipeline Insight, 2017 US$ 1,250.00 Nov, 2017 50 pages
Aspergillosis - Pipeline Insight, 2017 US$ 1,500.00 Nov, 2017 70 pages
Adderall- Drug Insights, 2017 US$ 1,000.00 Nov, 2017 35 pages
Hyperkalemia - Epidemiology Forecast to 2025 US$ 2,950.00 Nov, 2017 40 pages
Cervical Dysplasia - Pipeline Insight, 2017 US$ 1,250.00 Nov, 2017 50 pages
Zejula- Drug Insights, 2017 US$ 1,000.00 Nov, 2017 35 pages
Unituxin- Drug Insights, 2017 US$ 1,000.00 Nov, 2017 35 pages
Sovaldi - API Insights, 2017 US$ 500.00 Nov, 2017 30 pages
Parkinson's Disease- Epidemiology Forecast to 2025 US$ 2,950.00 Nov, 2017 40 pages
Movantik- Drug Insights, 2017 US$ 1,000.00 Nov, 2017 35 pages
Invega Sustenna/Xeplion- Drug Insights, 2017 US$ 1,000.00 Nov, 2017 35 pages
Endometriosis- Pipeline Insights, 2017 US$ 1,500.00 Nov, 2017 108 pages
Cubicin - API Insights, 2017 US$ 500.00 Nov, 2017 30 pages
Chikungunya - Pipeline Insight, 2017 US$ 1,500.00 Nov, 2017 70 pages
BeneFIX  - API Insights, 2017 US$ 500.00 Nov, 2017 30 pages
Axiron - API Insights, 2017 US$ 500.00 Nov, 2017 30 pages
Anesthetic Effect - Epidemiology Forecast to 2025 US$ 2,950.00 Nov, 2017 40 pages
Acromegaly - Epidemiology Forecast to 2025 US$ 2,950.00 Nov, 2017 40 pages
Zienam- Drug Insights, 2017 US$ 1,000.00 Nov, 2017 35 pages
Xeroquel LP - API Insights, 2017 US$ 500.00 Nov, 2017 30 pages
Tracleer- Drug Insights, 2017 US$ 1,000.00 Nov, 2017 35 pages
Taxotere - API Insights, 2017 US$ 500.00 Nov, 2017 30 pages
Kallikrein Inhibitor -Pipeline Insights, 2017 US$ 1,250.00 Nov, 2017 60 pages
1 2 3 4 5 ... 47
Skip to top

Analytics, News & Press-Releases by DelveInsight